COMPOUND PROFILE / SMALL MOLECULES
Dihexa.
Research draftDihexa is an experimental peptide-derived neuroactive compound.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Dihexa is an experimental peptide-derived neuroactive compound.
Mechanism
HGF/c-Met-related activity has been proposed, but a central mechanism paper was retracted. The claim should not be presented as settled.
Human research
Direct therapeutic human evidence was not established.
Preclinical & other research
A foundational cognition and synaptic-mechanism paper was retracted in 2025. It is excluded as positive supporting evidence; the retraction is retained for transparency.
Safety & unknowns
Human safety is unknown; growth-factor pathway activity creates unanswered questions rather than proof of benefit.
Regulatory status
Research compound, not an established nootropic medicine.
Reported use & evidence
The supplied Dihexa profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.